Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
The Cell Cycle Control System01:28

The Cell Cycle Control System

2.6K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DUSP1 is a Key Driver of Disease Persistence and Potential Therapeutic Target in Hairy Cell Leukemia.

Blood advances·2026
Same author

CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment.

HemaSphere·2026
Same author

CNOT3 supports ILC2 differentiation and function by destabilizing Tbx21 and Rorc transcripts.

The Journal of experimental medicine·2026
Same author

Innate lymphoid cells integrate sensing and plasticity to control fungal infections.

Cell reports·2026
Same author

Platelets accelerate endoplasmic reticulum stress and promote hepatic steatosis.

JHEP reports : innovation in hepatology·2026
Same author

Reactivation of the silenced <i>BASP1</i> gene suppresses oncogenic WNT signaling in human colorectal cancer cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: May 29, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Cdk6's functions are critically regulated by its unique C-terminus.

Alessia Schirripa1, Helge Schöppe2, Sofie Nebenfuehr1

  • 1Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.

Iscience
|February 3, 2025
PubMed
Summary
This summary is machine-generated.

The C-terminus of CDK6 (cyclin-dependent kinase 6) is crucial for its function in promoting cell proliferation. Truncating this part impairs nuclear translocation and binding to key partners, hindering leukemia progression.

Keywords:
BiochemistryCancerMolecular StructureStructural biology

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.5K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

11.8K

Related Experiment Videos

Last Updated: May 29, 2025

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.5K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

11.8K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cell cycle regulation is vital and its disruption is a hallmark of cancer.
  • Cyclin-dependent kinase 6 (CDK6) is a central signaling hub in the cell cycle, with its activity modulated by interacting proteins.

Purpose of the Study:

  • To investigate the functional significance of the C-terminus of CDK6 in a leukemia model.
  • To elucidate the role of the CDK6 C-terminus in protein interactions, nuclear translocation, and proliferation.

Main Methods:

  • Analysis of C-terminally truncated Cdk6 (Cdk6 ΔC) in a leukemia model.
  • Proteomic analysis and protein modeling to assess protein interactions and structural flexibility.
  • Evaluation of nuclear translocation, chromatin interaction, proliferation, and disease progression.

Main Results:

  • C-terminally truncated Cdk6 (Cdk6 ΔC) exhibited reduced nuclear translocation and chromatin interaction.
  • Cdk6 ΔC failed to enhance proliferation and disease progression in the leukemia model.
  • The C-terminus was identified as essential for CDK6 flexibility and binding to cyclin D, p27Kip1, and INK4 proteins, but not cyclin B.

Conclusions:

  • The C-terminus is a critical regulatory domain of CDK6, essential for its interaction with key partners and overall functionality.
  • Disruption of the CDK6 C-terminus significantly impairs its role in promoting cell proliferation and disease progression.
  • Targeting the CDK6 C-terminus could offer a novel therapeutic strategy for cancers driven by CDK6 dysregulation.